BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26047477)

  • 1. Tumor-Targeting Salmonella typhimurium A1-R in Combination with Trastuzumab Eradicates HER-2-Positive Cervical Cancer Cells in Patient-Derived Mouse Models.
    Hiroshima Y; Zhang Y; Zhao M; Zhang N; Murakami T; Maawy A; Mii S; Uehara F; Yamamoto M; Miwa S; Yano S; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Endo I; Hoffman RM
    PLoS One; 2015; 10(6):e0120358. PubMed ID: 26047477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic.
    Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Miyake M; Li S; Han Q; Tan Y; Zhao M; Li Y; Nelson SD; Dry SM; Singh AS; Elliott IA; Russell TA; Eckardt MA; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM
    Cell Cycle; 2018; 17(6):801-809. PubMed ID: 29374999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model.
    Miyake K; Murata T; Murakami T; Zhao M; Kiyuna T; Kawaguchi K; Igarashi K; Miyake M; Lwin TM; Hozumi C; Komatsu S; Kikuchi T; Bouvet M; Shimoya K; Singh SR; Endo I; Hoffman RM
    Arch Gynecol Obstet; 2019 Jun; 299(6):1683-1690. PubMed ID: 30953192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-targeting Salmonella typhimurium A1-R overcomes partial carboplatinum-resistance of a cancer of unknown primary (CUP).
    Miyake K; Kiyuna T; Miyake M; Zhao M; Wangsiricharoen S; Kawaguchi K; Zhang Z; Higuchi T; Razmjooei S; Li Y; Nelson SD; Russell T; Singh A; Murakami T; Hiroshima Y; Momiyama M; Matsuyama R; Chishima T; Singh SR; Chawla SP; Eilber FC; Endo I; Hoffman RM
    Tissue Cell; 2018 Oct; 54():144-149. PubMed ID: 30309504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide.
    Kawaguchi K; Igarashi K; Murakami T; Kiyuna T; Zhao M; Zhang Y; Nelson SD; Russell TA; Dry SM; Singh AS; Chmielowski B; Li Y; Unno M; Eilber FC; Hoffman RM
    Cell Cycle; 2017 Jul; 16(13):1288-1294. PubMed ID: 28622068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8
    Murakami T; Hiroshima Y; Zhang Y; Zhao M; Kiyuna T; Hwang HK; Miyake K; Homma Y; Mori R; Matsuyama R; Chishima T; Ichikawa Y; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Cell Biochem; 2018 Jan; 119(1):634-639. PubMed ID: 28628234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor targeting Salmonella typhimurium A1-R in combination with gemcitabine (GEM) regresses partially GEM-resistant pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse models.
    Kawaguchi K; Miyake K; Zhao M; Kiyuna T; Igarashi K; Miyake M; Higuchi T; Oshiro H; Bouvet M; Unno M; Hoffman RM
    Cell Cycle; 2018; 17(16):2019-2026. PubMed ID: 29963961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining Tumor-Selective Bacterial Therapy with Salmonella typhimurium A1-R and Cancer Metabolism Targeting with Oral Recombinant Methioninase Regressed an Ewing's Sarcoma in a Patient-Derived Orthotopic Xenograft Model.
    Miyake K; Kiyuna T; Li S; Han Q; Tan Y; Zhao M; Oshiro H; Kawaguchi K; Higuchi T; Zhang Z; Razmjooei S; Barangi M; Wangsiricharoen S; Murakami T; Singh AS; Li Y; Nelson SD; Eilber FC; Bouvet M; Hiroshima Y; Chishima T; Matsuyama R; Singh SR; Endo I; Hoffman RM
    Chemotherapy; 2018; 63(5):278-283. PubMed ID: 30673664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Methioninase Combined With Tumor-targeting
    Igarashi K; Kawaguchi K; Zhao M; Han Q; Tan Y; Kiyuna T; Miyake K; Higuchi T; Nelson SD; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Singh SR; Tsuchiya H; Hoffman RM
    Anticancer Res; 2020 May; 40(5):2515-2523. PubMed ID: 32366396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Targeting Salmonella typhimurium A1-R Arrests a Chemo-Resistant Patient Soft-Tissue Sarcoma in Nude Mice.
    Hiroshima Y; Zhao M; Zhang Y; Zhang N; Maawy A; Murakami T; Mii S; Uehara F; Yamamoto M; Miwa S; Yano S; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Endo I; Hoffman RM
    PLoS One; 2015; 10(8):e0134324. PubMed ID: 26237416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of tumor-targeting Salmonella typhimurium A1-R and oral recombinant methioninase regresses a BRAF-V600E-negative melanoma.
    Kawaguchi K; Higuchi T; Li S; Han Q; Tan Y; Igarashi K; Zhao M; Miyake K; Kiyuna T; Miyake M; Ohshiro H; Sugisawa N; Zhang Z; Razmjooei S; Wangsiricharoen S; Chmielowski B; Nelson SD; Russell TA; Dry SM; Li Y; Eckardt MA; Singh AS; Singh SR; Eilber FC; Unno M; Hoffman RM
    Biochem Biophys Res Commun; 2018 Sep; 503(4):3086-3092. PubMed ID: 30166061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model.
    Kawaguchi K; Igarashi K; Murakami T; Chmielowski B; Kiyuna T; Zhao M; Zhang Y; Singh A; Unno M; Nelson SD; Russell TA; Dry SM; Li Y; Eilber FC; Hoffman RM
    Oncotarget; 2016 Dec; 7(52):85929-85936. PubMed ID: 27835903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Tumor-Targeting
    Murakami T; Hiroshima Y; Miyake K; Kiyuna T; Endo I; Zhao M; Hoffman RM
    Cells; 2019 Jun; 8(6):. PubMed ID: 31208120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
    Kawaguchi K; Igarashi K; Murakami T; Zhao M; Zhang Y; Chmielowski B; Kiyuna T; Nelson SD; Russell TA; Dry SM; Li Y; Unno M; Eilber FC; Hoffman RM
    J Cell Biochem; 2017 Aug; 118(8):2314-2319. PubMed ID: 28106277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model.
    Momiyama M; Zhao M; Kimura H; Tran B; Chishima T; Bouvet M; Endo I; Hoffman RM
    Cell Cycle; 2012 Feb; 11(3):628-32. PubMed ID: 22274398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Targeting Salmonella typhimurium A1-R: An Overview.
    Hoffman RM
    Methods Mol Biol; 2016; 1409():1-8. PubMed ID: 26846797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model.
    Murakami T; DeLong J; Eilber FC; Zhao M; Zhang Y; Zhang N; Singh A; Russell T; Deng S; Reynoso J; Quan C; Hiroshima Y; Matsuyama R; Chishima T; Tanaka K; Bouvet M; Chawla S; Endo I; Hoffman RM
    Oncotarget; 2016 Mar; 7(11):12783-90. PubMed ID: 26859573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model.
    Kiyuna T; Murakami T; Tome Y; Kawaguchi K; Igarashi K; Zhang Y; Zhao M; Li Y; Bouvet M; Kanaya F; Singh A; Dry S; Eilber FC; Hoffman RM
    Oncotarget; 2016 May; 7(22):33046-54. PubMed ID: 27105519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-efficacy targeting of colon-cancer liver metastasis with Salmonella typhimurium A1-R via intra-portal-vein injection in orthotopic nude-mouse models.
    Kawaguchi K; Murakami T; Suetsugu A; Kiyuna T; Igarashi K; Hiroshima Y; Zhao M; Zhang Y; Bouvet M; Clary BM; Unno M; Hoffman RM
    Oncotarget; 2017 Mar; 8(12):19065-19073. PubMed ID: 27683127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-targeting Salmonella typhimurium A1-R arrests a doxorubicin-resistant PDGFRA-amplified patient-derived orthotopic xenograft mouse model of pleomorphic liposarcoma.
    Kiyuna T; Tome Y; Murakami T; Zhao M; Miyake K; Igarashi K; Kawaguchi K; Miyake M; Oshiro H; Higuchi T; Li Y; Dry SM; Nelson SD; Russell TA; Eckardt MA; Singh AS; Kanaya F; Eilber FC; Hoffman RM
    J Cell Biochem; 2018 Sep; 119(9):7827-7833. PubMed ID: 29932244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.